Furthermore, CVD risk in hypertension patients is more closely associated with the levels of apolipoprotein, which plays a crucial role in the protective functions of HDL, than with the quantitative levels of HDL-C [12], whereby CVD patients have low concentrations of serum apolipoprotein A1 (ApoA1) [13]. The gene discussed is APOA1; the disease is Hypertension.